Glenmark Pharmaceuticals Limited is a global pharmaceutical company headquartered in Mumbai, India. Established in 1977, the company has grown to become a
Categories
pharmaceuticals
Earnings | BDH Industries Ltd. (NSE: BDH): Q4FY23 Results Out; Total Income rises 77% YoY.
BDH Industries Ltd. is a manufacturing company that specializes in the production of therapeutic formulations, encompassing a wide range of pharmaceutical products.
Zydus Lifescience Ltd Q4FY23 results out, revenue grows by 32%
In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble
Earnings Summary Of Gland Pharma Limited For Q4 FY23
Gland Pharma Limited specializes in the production of sterile injectable formulations, including vials, ampoules, pre-filled syringes, and lyophilized products. The company's focus
Earnings Summary Of Glaxosmithkline Pharmaceuticals Limited For Q4 FY23
GlaxoSmithKline Pharmaceuticals Limited is a renowned Indian pharmaceutical company that operates in the research, development, manufacturing, and marketing of a wide range
Granules India Ltd (GRANULES) Q4 FY23 Earnings Concall Transcript
Granules India Ltd (NSE:GRANULES) Q4 FY23 Earnings Concall dated May. 16, 2023. Corporate Participants: Irfan Raeen -- Investor Relations Krishna Prasad -- Chairman and Managing Director
Granules India Limited Q4 FY23; Net Profit Increased By 8%
Granules India Limited reported Total Income for Q4 FY23 of ₹1,198.87 Crore up from ₹1,033.93 Crore year on year, a growth of
Earnings Summary Of Granules India Limited For Q4 FY23
Granules India Limited is a pharmaceutical manufacturing company based in India. The company is engaged in the production and sale of active
Themis Medicare Ltd (THEMISMED) Q4 FY23 Earnings Concall Transcript
Themis Medicare Ltd (NSE: THEMISMED) Q4 FY23 earnings concall dated May. 15, 2023 Corporate Participants: Sachin Patel -- Managing Director and Chief Executive Officer
Gujarat Themis Biosyn Limited (506879) Q4 FY23 Earnings Concall Transcript
Gujarat Themis Biosyn Limited (NSE: 506879) Q4 FY23 earnings concall dated May. 15, 2023 Corporate Participants: Sachin Dinesh Patel -- Director Rajneesh Anand -- Consultant Tushar
Cipla Limited Q4 FY23 Earnings Conference Call Insights
Key highlights from Cipla Limited (CIPLA) Q4 FY23 Earnings Concall Management Update: [00:05:08] CIPLA said its U.S. business crossed $200 million in
Solara Active Pharma Sciences Limited (SOLARA) Q4 FY23 Earnings Concall Transcript
Solara Active Pharma Sciences Limited (NSE:SOLARA) Q4 FY23 Earnings Concall dated May. 12, 2023. Corporate Participants: Abhishek Singhal -- Investor Relations Jitesh Devendra -- Managing Director
Solara Active Pharma Q4FY23 results out, revenue grows by 6%
Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of APIs.
Cipla Limited Q4 FY23; Consolidated Net Profit Jumped By 41%
Cipla Limited reported Total Income for Q4 FY23 of ₹5,873.93 Crore up from ₹5,324.35 Crore year on year, a growth of 10.3%.
Dr. Reddy’s Laboratories Q4 FY23 Earnings Conference Call Insights
Key highlights from Dr. Reddy's Laboratories (DRREDDY) Q4 FY23 Earnings Concall Q&A Highlights: [00:21:55] Mikhaila at Barclays asked more details about the
Aarti Industries Ltd Q4 FY23 Earnings Conference Call Insights
Key highlights from Aarti Industries Ltd (AARTIIND) Q4 FY23 Earnings Concall Management Update: [00:08:20] AARTIIND said its EBITDA growth guidance for FY24
Dr Reddy’s Laboratories Q4 FY23; Net Profit Surged Up To ₹960 Crore
Dr. Reddy’s Laboratories Limited reported Total Income for Q4 FY23 of ₹6,453.7 Crore up from ₹5,596.8 Crore year on year, a growth
Sanofi Ltd Q4FY23 results out, revenue soars by 4%
Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products. Company has three brands (Lantus, Allegra, Combiflam) in top
Earnings Summary Of Dr Reddy ‘s Laboratories Limited For Q4 FY23
Dr. Reddy's Laboratories Limited is an Indian multinational pharmaceutical company with a presence in over 25 countries. It was founded in 1984
Alembic Pharmaceuticals Limited (APLLTD) Q4 FY23 Earnings Concall Transcript
Alembic Pharmaceuticals Limited (NSE:APLLTD) Q4 FY23 Earnings Concall dated May. 05, 2023. Corporate Participants: Raj Kumar Baheti -- Director, Finance & Chief Financial Officer
Tatva Chintan Pharma Chem Limited (TATVA) Q4 FY23 Earnings Concall Transcript
Tatva Chintan Pharma Chem Limited (NSE:TATVA) Q4 FY23 Earnings Concall dated May. 05, 2023. Corporate Participants: Dinesh Sodani -- GM Finance Chintan Shah -- Managing Director